Skip to content

Idexx Laboratories IDXX Net Investment in Lease

Net Investment in Lease at other companies

Neogen logo
NeogenNEOG
Zoetis logo
ZoetisZTS
Danaher logo
DanaherDHR
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Agilent Technologies logo
Agilent TechnologiesA
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's net investment in lease?
Idexx Laboratories (IDXX) reported net investment in lease of $121.4M in Q1 2026.
How has Idexx Laboratories's net investment in lease changed year-over-year?
Idexx Laboratories's net investment in lease increased by 4.7% year-over-year, from $116M to $121.4M.
What is the long-term trend for Idexx Laboratories's net investment in lease?
Over 5 years (2020 to 2025), Idexx Laboratories's net investment in lease has grown at a 61.8% compound annual growth rate (CAGR), from $11.1M to $123.23M.